Adult Mesenchymal Stem Cells Manage the Body’s Innate Regenerative Capability     Arnold Caplan, Ph.D
Intranasal Stem Cells and T Cells Bypass the Blood-Brain Barrier to Treat CNS Disorders while Reducing Systemic Exposure           William Frey, II Ph.D
Non-Myeloablative and Chemotherapy-free Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Sickle Cell Disease (SCD) Damiano Ronelli, MD
Intranasal Cell Therapy for Alzheimer’s, Parkinson’s and Glioma Lucine Danielyan, MD
Cystic Fibrosis and MSCs   Tracey Bonfield, Ph.D.
Stem Cell Educator Therapy in Alopecia Areata Subjects: Phase I/II Clinical Trial YongZhao, MD, PhD
Stem Cells for Cardiovascular Disease  Leslie Miller, MD
The Dilemma of Difficult Diseases: Cell Therapy to the Rescue?  Mark Holterman, MD PhD

CellR4 and the Alliance for the Advancement of Cellular Therapies, AACT, collaborate to publish the proceedings of the AACT 2015 Conference titled “The Dilemma of Difficult Diseases: Cell Therapy to the Rescue?”. The abstracts of the conference may be found at http://cellr4.org.

CellR4 is a journal with particular focus on cellular repair, replacement, regeneration, reprogramming and differentiation. Its scope ranges from fundamental new discoveries in basic science to translational, clinical trials and delivery of novel therapeutic options. As the official journal of CellR4 will also serve as a platform for discussion of challenges and opportunities on the path to the development of new treatments, independently from the disease target. Therefore, besides original articles, reviews, case reports and letters, CellR4 will also publish commentaries/opinion papers on regulatory, legal, and ethical issues, as well as publish information on global collaborative platforms and funding opportunities of interest to the field.

CellR4 is the official journal of the Cure Alliance.